Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Schlumberger NV (SLB) vs 22nd Century Group Inc (XXII) Price & Performance

Schlumberger NVTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Schlumberger NV vs 22nd Century Group Inc — how do they compare? Schlumberger NV trades at $52.95 (market cap $79.67B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Schlumberger NV is far larger — about 52414.5× 22nd Century Group Inc's market cap, and Schlumberger NV pays a 2.2% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.

SLBXXII
Market Cap
$79.67B$1.52M
Sector
EnergyTechnology
52-Week High
$58.01$801.00
52-Week Low
$31.72$3.72
Enterprise Value
$88.40B-$6.71M
Dividend Yield
2.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Schlumberger NV

SLB trades at $52.96, down 0.45% on the day, with a bullish technical signal from moving averages and oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $0.55, and maintains a consensus analyst price target of $63.00. Revenue for 2025 was $35.71 billion, with a net income margin of 8.53%, though margins have softened from prior years. Recent news highlights growth in digital and offshore segments, offset by Middle East challenges.

The outlook for SLB is positive, driven by earnings beats and robust analyst support, but risks include regional volatility and margin pressure. Upside potential exists if digital and production gains accelerate, yet investors must weigh debt levels and geopolitical headwinds against the stock's current valuation near 52-week highs.

22nd Century Group Inc

XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.

The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Schlumberger NV

Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.

Read more on SLB

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII